ACCARDI, FABRIZIO
 Distribuzione geografica
Continente #
NA - Nord America 396
EU - Europa 349
AS - Asia 145
AF - Africa 14
Continente sconosciuto - Info sul continente non disponibili 2
Totale 906
Nazione #
US - Stati Uniti d'America 383
SE - Svezia 134
CN - Cina 104
IE - Irlanda 80
IT - Italia 44
TR - Turchia 27
DE - Germania 19
CI - Costa d'Avorio 14
CA - Canada 13
RO - Romania 13
SG - Singapore 11
FI - Finlandia 10
AT - Austria 9
CZ - Repubblica Ceca 8
FR - Francia 8
BE - Belgio 7
ES - Italia 4
GB - Regno Unito 4
UA - Ucraina 3
EU - Europa 2
IN - India 2
NL - Olanda 2
BG - Bulgaria 1
IR - Iran 1
LU - Lussemburgo 1
NO - Norvegia 1
RS - Serbia 1
Totale 906
Città #
Chandler 110
Dublin 80
Ashburn 39
Ann Arbor 34
Izmir 24
Shanghai 23
Dearborn 21
New York 20
Nanjing 15
Abidjan 14
Focsani 13
Princeton 13
Toronto 13
Parma 12
Beijing 11
Helsinki 10
Vienna 9
Hebei 8
Singapore 8
Boardman 7
Bremen 7
Brussels 7
Shenyang 7
Brno 6
Romainville 6
Milan 5
Munich 5
Rho 5
Wilmington 5
Hefei 4
Kunming 4
Los Angeles 4
Madrid 4
Nanchang 4
San Mateo 4
Changsha 3
Des Moines 3
Guangzhou 3
Jinan 3
Kocaeli 3
Norwalk 3
Tianjin 3
Woodbridge 3
Zhengzhou 3
Deiva Marina 2
Florence 2
Jacksonville 2
Jiaxing 2
Modena 2
Redwood City 2
Seattle 2
Torino 2
Waltham 2
Amsterdam 1
Aosta 1
Belgrade 1
Borås 1
Buffalo 1
Chengdu 1
Edinburgh 1
Fremont 1
Haikou 1
Houston 1
Huizen 1
Luxembourg 1
Marseille 1
Miami 1
Mountain View 1
Orange 1
Oslo 1
Rome 1
Sabz 1
Sofia 1
Somerville 1
Velletri 1
Walnut 1
Xian 1
Totale 630
Nome #
Neurofibromatosis type I and multiple myeloma coexistence: A possible link? 91
Bone marrow CX3CL1/Fractalkine is a new player of the pro-angiogenic microenvironment in multiple myeloma patients 88
Bone marrow Dikkopf-1 levels are a new independent risk factor for progression in patients with smouldering myeloma 81
Expression of CD38 in myeloma bone niche: A rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formation 79
Novel targets for the treatment of relapsing multiple myeloma 79
The Proteasome and Myeloma-Associated Bone Disease 75
Addition of Bortezomib to High Dose Melphalan As Conditioning Regimen for Autologous Stem Cell Transplantation Improves the Response Rate in Newly Diagnosed Multiple Myeloma Patients 70
A Rare Case of Systemic AL Amyloidosis with Muscle Involvement: A Misleading Diagnosis 68
Phase II Study of the Combination of Interleukin-2 with Zoledronic Acid As Maintenance Therapy Following Autologous Stem Cell Transplant in Patients with Multiple Myeloma 66
EXPRESSION OF CD38 AND ECTOENZYMES OF THE ADENOSINERGIC PATHWAYS IN MYELOMA BONE NICHE: A RATIONAL BASIS FOR THE USE OF DARATUMUMAB TO TARGET OSTEOCLAST FORMATION IN MULTIPLE MYELOMA 65
Lenalidomide increases human dendritic cell maturation in multiple myeloma patients targeting monocyte differentiation and modulating mesenchymal stromal cell inhibitory properties 60
Monoclonal and Bispecific Anti-BCMA Antibodies in Multiple Myeloma 56
Combining bortezomib to high dose melphalan as conditioning regimen results in the improvement of the response rate in newly diagnosed young multiple myeloma patients 50
CD38 expression by plasma cells in extramedullary multiple myeloma 10
Totale 938
Categoria #
all - tutte 3.463
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.463


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020117 25 12 1 3 6 25 12 2 14 12 1 4
2020/202162 2 1 6 1 21 4 2 2 11 4 3 5
2021/2022107 1 4 3 22 0 2 17 5 4 3 16 30
2022/2023395 58 54 19 29 46 29 23 16 96 4 16 5
2023/2024147 3 11 3 4 16 46 7 9 1 7 10 30
2024/202515 15 0 0 0 0 0 0 0 0 0 0 0
Totale 938